DNA-probes based diagnostics have the potential to be widely used in new disease management, according to a new study by Fact.MR. The efficacy of DNA sequencing in detection of alterations continues to drive their adoption in R&D.
DNA probes-based diagnostics examines the undoing of anomalous gene sequence that is present in the DNA strand. This technology is used in instrumentation development, surface chemistry, molecular biology, data handling, biological sample preparation and microfabrication. Increasing awareness of DNA probes based diagnostics for prenatal diagnosis and carrier detection is expected to drive demand.
For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=5474
Rise in the emergence of infectious diseases has increased the use of DNA probe based diagnostics in the diagnosis of bacterial infections caused by Salmonella typhi (food poisoning), Escherichia coli (gastroenteritis), and Campylobacter hyointestinalis. The introduction of new technologies for high volume testing is expected to propel market growth.
• Global revenues to grow at over 5% CAGR through 2030
• Introduction of in-situ hybridization with non-isotopic DNA probes creating opportunities in infectious disease testing segment
• Increasing need for molecular diagnosis of diseases like cancer remains a key opportunity
• Limitations due to errors caused by recombination between the marker and disease alleles, incorrect pedigree data and genetic heterogeneity.
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=5474
“Increasing geriatric population and rising disposable income among the masses is expected to increase demand for DNA probes based diagnostics in the market. New developments are expected to increase competition among the players,” says an analyst at Fact.MR.
COVID-19 Impact Analysis
The COVID-19 pandemic has disrupted industries all over the world, and the healthcare industry is no different. The market, however, experienced demand due to increasing need for diagnostics during the pandemic. The market is likely to witness steady demand for DNA probe based diagnostics following the advent of the COVID-19 pandemic.
For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=5474
Who Is Winning?
US, UK, Germany, France, and Italy remain some of the prominent markets for DNA probes globally. Market players are now focusing on developing better and faster technologies. Rising use of automation in diagnosis or testing has created lucrative opportunities for market players.
Some of the key players in the DNA probe based diagnostics market are Abbott Molecular, Beckman Coulter Inc., Becton, Dickinson and Company, bioMérieux, F. Hoffmann-La Roche Ltd., GE Healthcare Life Sciences, Luminex Corporation, QIAGEN N.V., Siemens Healthineers and Thermo Fischer Scientific Inc.
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583